Re-Innovating Dexmedetomidine (RE03) for the Treatment of stress-induced Insomnia

• Unité de recherche: INNOSUISSE
• Numéro de projet: 119.703 IP-LS
• Titre du projet anglais: Re-Innovating Dexmedetomidine (RE03) for the Treatment of stress-induced Insomnia

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

Insomnia represents a predisposing, perpetuating and precipitating factor in PTSD. Current sleep medications show poor clinical efficacy, leaving an urgent unmet need. Reconnect is committed to develop an innovative sleep medication to break the vicious cycle of hyperarousal-related insomnia in PTSD